Skip to main content
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. logo

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. — Investor Relations & Filings

Ticker · 603882 ISIN · CNE100002VW1 Shanghai Stock Exchange Human health and social work activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2026-05-06 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 603882

About GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

https://en.kingmed.com.cn/

Guangzhou KingMed Diagnostics Group Co., Ltd. is a leading independent clinical laboratory service provider. The company specializes in providing comprehensive medical diagnostic testing services to healthcare institutions, including hospitals, clinics, and health check-up centers. Its extensive service portfolio encompasses clinical chemistry, immunology, hematology, molecular genetics, and anatomical pathology. The group operates a vast network of regional laboratories equipped with advanced diagnostic technologies such as next-generation sequencing and mass spectrometry. It is recognized for its commitment to quality, holding international accreditations like CAP and ISO 15189. Beyond clinical diagnostics, it offers specialized services in clinical trial support, food and hygiene testing, and precision medicine. By leveraging a robust cold-chain logistics system, the organization ensures efficient sample collection and rapid turnaround times across its service areas.

Recent filings

Filing Released Lang Actions
广州金域医学检验集团股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, the price range, the total amount spent, and the purpose of the repurchase (employee stock ownership plan or equity incentives). It references previous announcements about the repurchase plan and funding adjustments. The document does not contain financial statements or earnings data but focuses on the update of the share buyback activity. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers company buyback or sale of its own shares.
2026-05-06 Chinese
广州金域医学检验集团股份有限公司二〇二五年度审计报告及财务报表
Audit Report / Information Classification · 92% confidence The document is titled “审计报告及财务报表” for the 2025 fiscal year and contains the auditor’s opinion, key audit matters, auditor responsibilities, and the full set of audited financial statements (consolidated and parent company balance sheets, profit & loss, cash flows, equity changes, and notes). It is a standalone audit report with financial statements rather than an annual management commentary or investor presentation. This corresponds to the Audit Report / Information category (AR). FY 2025
2026-04-24 Chinese
广州金域医学检验集团股份有限公司2025年年度报告
Annual Report Classification · 100% confidence The document is titled "广州金域医学检验集团股份有限公司2025 年年度报告" which translates to "Guangzhou Kingmed Diagnostics Group Co., Ltd. 2025 Annual Report." It contains detailed sections including Chairman's statement, company information, financial data for the year 2025, quarterly financial data, non-recurring gains and losses, and other comprehensive financial and operational information. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements and management discussion and analysis, which are typical components of an Annual Report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K).
2026-04-24 Chinese
广州金域医学检验集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the shareholding situation of the top ten shareholders and top ten unrestricted shareholders prior to a share repurchase plan approved by the company's board. It references a previous announcement about the share repurchase plan and provides detailed shareholding data as of a specific date. The content focuses on shareholding changes related to a share buyback, not on financial results, management changes, or other report types. The document length is short (1668 characters) and it is a formal announcement of shareholding status in relation to a share repurchase. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2026-04-15 Chinese
广州金域医学检验集团股份有限公司关于以集中竞价交易方式首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Guangzhou Kingmed Diagnostics Group Co., Ltd. regarding the company's first share repurchase through centralized bidding. It details the repurchase plan, the amount, price range, and the purpose of the repurchase (employee stock ownership plan or equity incentive). The document includes specific data on shares repurchased, prices, and total amount spent. It is a formal announcement about the company's share buyback activity, not a full financial report or earnings release. The content matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company buying back its own shares.
2026-04-13 Chinese
广州金域医学检验集团股份有限公司关于以集中竞价交易方式回购股份的回购报告书
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Guangzhou Kingmed Diagnostics Group Co., Ltd. regarding a share repurchase plan. It includes specifics such as the amount of shares to be repurchased, price limits, funding sources, purpose (employee stock ownership plan or equity incentives), implementation procedures, risks, and authorizations. The document is not a financial report or earnings release but a formal disclosure about the company's intention and plan to buy back its own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements and related details. The document length and content confirm it is the actual announcement of the repurchase plan, not a brief notice or a report publication announcement.
2026-04-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.